Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review

J Sarris, J Sinclair, D Karamacoska, M Davidson, J Firth - BMC psychiatry, 2020 - Springer
Background Medicinal cannabis has received increased research attention over recent
years due to loosening global regulatory changes. Medicinal cannabis has been reported to …

Cannabis and the develo** brain: insights into its long-lasting effects

YL Hurd, OJ Manzoni, MV Pletnikov, FS Lee… - Journal of …, 2019 - Soc Neuroscience
The recent shift in sociopolitical debates and growing liberalization of cannabis use across
the globe has raised concern regarding its impact on vulnerable populations, such as …

Cannabis use disorder and subsequent risk of psychotic and nonpsychotic unipolar depression and bipolar disorder

OH Jefsen, A Erlangsen, M Nordentoft… - JAMA psychiatry, 2023 - jamanetwork.com
Importance Cannabis use is increasing worldwide and is suspected to be associated with
increased risk of psychiatric disorders; however, the association with affective disorders has …

Cannabidiol as a potential treatment for psychosis

C Davies, S Bhattacharyya - Therapeutic advances in …, 2019 - journals.sagepub.com
Psychotic disorders such as schizophrenia are heterogeneous and often debilitating
conditions that contribute substantially to the global burden of disease. The introduction of …

The why behind the high: determinants of neurocognition during acute cannabis exposure

JG Ramaekers, NL Mason, L Kloft… - Nature Reviews …, 2021 - nature.com
Acute cannabis intoxication may induce neurocognitive impairment and is a possible cause
of human error, injury and psychological distress. One of the major concerns raised about …

Deconstructing the neurobiology of cannabis use disorder

JMN Ferland, YL Hurd - Nature Neuroscience, 2020 - nature.com
There have been dramatic changes worldwide in the attitudes toward and consumption of
recreational and medical cannabis. Cannabinoid receptors, which mediate the actions of …

Cannabidiol counteracts the psychotropic side-effects of δ-9-tetrahydrocannabinol in the ventral hippocampus through bidirectional control of erk1–2 phosphorylation

R Hudson, J Renard, C Norris, WJ Rushlow… - Journal of …, 2019 - Soc Neuroscience
Evidence suggests that the phytocannabinoids Δ-9-tetrahydrocannabinol (THC) and
cannabidiol (CBD) differentially regulate salience attribution and psychiatric risk. The ventral …

Blunted highs: pharmacodynamic and behavioral models of cannabis tolerance

JG Ramaekers, NL Mason, EL Theunissen - European …, 2020 - Elsevier
Acute exposure to cannabis comes with neurocognitive impairment, leading to increased
risk of human error and injury. Evidence however indicates that such acute effects are less …

Cannabis and psychosis: are we any closer to understanding the relationship?

I Hamilton, M Monaghan - Current Psychiatry Reports, 2019 - Springer
Abstract Purpose of Review This paper provides an update from the literature on
understanding of the relationship between cannabis and schizophrenia. In particular, the …

The Yin and Yang of Cannabis: a systematic review of human neuroimaging evidence of the differential effects of Δ9-tetrahydrocannabinol and cannabidiol

B Gunasekera, C Davies, R Martin-Santos… - Biological Psychiatry …, 2021 - Elsevier
Abstract Cannabidiol (CBD) and Δ 9-tetrahydrocannabinol (THC) have been the most
investigated cannabinoids at the human and preclinical levels, although the neurobiological …